Qualifying conditions include type 2 diabetes, prediabetes, high blood pressure, high cholesterol, sleep apnea, PCOS, fatty liver disease, cardiovascular disease, insulin resistance, metabolic syndrome, and weight-related joint pain
What The Study Found Patients taking GLP-1 drugs had: Fewer complications after kidney surgery Less kidney damage Fewer heart rhythm problems Fewer hospital readmissions Even more surprising: Patients taking GLP-1 drugs lived longer when followed up 23 years after surgery than patients not taking these drugs
Safety Profile Sublingual semaglutide is generally well-tolerated, with most side effects being gastrointestinal disturbances such as nausea and diarrhea
Through the combined application of genetic engineering, synthetic biology, and nanotechnology, we aim to clarify the optimization strategies of engineered live bacteria
One-way ANOVA showed significant differences between the groups in terms of age ( p = 0.001), hence age was included as a covariate in between group comparisons of metabolite concentrations